Allworth Financial’s Definium Therapeutics DFTX Stock Holding History

Allworth Financial’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110K	Buy	2,336 +2,209	+1,739%	+$54.6K	﹤0.01%	1885
2026 Q1	$2.4K	Sell	127 -21	-14%	-$356	﹤0.01%	4290
2025 Q4	$1.98K	Buy	148 +63	+74%	+$780	﹤0.01%	4127
2025 Q3	$1K	Hold	85	–	–	﹤0.01%	4250
2025 Q2	$552	Buy	85 +16	+23%	+$105	﹤0.01%	4113
2025 Q1	$444	Hold	69	–	–	﹤0.01%	3713
2024 Q4	$484	Buy	69 +3	+5%	+$21	﹤0.01%	3611
2024 Q3	$376	Hold	66	–	–	﹤0.01%	3480
2024 Q2	$524	Hold	66	–	–	﹤0.01%	3356
2024 Q1	$621	Hold	66	–	–	﹤0.01%	3225
2023 Q4	$242	Hold	66	–	–	﹤0.01%	3266
2023 Q3	$207	Hold	66	–	–	﹤0.01%	3225
2023 Q2	$236	Hold	66	–	–	﹤0.01%	3066
2023 Q1	$210	Hold	66	–	–	﹤0.01%	3000
2022 Q4	$145	Sell	66 -16	-20%	-$44	﹤0.01%	2868
2022 Q3	$0	Buy	82 +15	+22%	+$144	﹤0.01%	2930
2022 Q2	$1K	Hold	67	–	–	﹤0.01%	2199
2022 Q1	$1K	Buy	+67	New	+$1.16K	﹤0.01%	1971

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Allworth Financial's DFTX Position: Q2 2026 in Review

Allworth Financial increased its Definium Therapeutics (DFTX) stake by 1,739% in Q2 2026, buying an estimated $54.6K and bringing the position to 2,336 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #1885.

Allworth Financial first reported a position in DFTX in Q1 2022 and has held it in 18 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Allworth Financial held 2,336 shares of Definium Therapeutics worth $110K as of Q2 2026.
Allworth Financial bought 2,209 Definium Therapeutics shares in Q2 2026, an estimated $54.6K.
Definium Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1885 holding.
Allworth Financial first reported a position in Definium Therapeutics in Q1 2022 and has held it in 18 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.